SCHEMBL19007833

SCHEMBL19007833

Cc1cccc2c1ncc1cccnc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 4/20 0.51
CCR8 P51685 4/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HTR1A P08908 1/20 0.47
ADRA1D P25100 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
NPC1 O15118 2/20 0.47
HSP90AA1 P07900 2/20 0.47
CCR5 P51681 3/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 3/20 0.46
CYP2A6 P11509 2/20 0.45
HTT P42858 2/20 0.43
PSMD14 O00487 1/20 0.43
COPS5 Q92905 1/20 0.43
SLC6A2 P23975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19007827 0.83 CYP2A6 (0.50) MEN1KMT2AHTR1AADRA1DADRA1A
SCHEMBL22333782 0.79 ALDH1A1 (0.50) CCR1CCR8MEN1KMT2ASMN1; SMN2
SCHEMBL256942 0.78 CCR1 (0.61) CCR1CCR8SMN1; SMN2ADRA1AL3MBTL1
SCHEMBL29664407 0.78 CCR1 (0.61) CCR1CCR8SMN1; SMN2ADRA1AL3MBTL1
SCHEMBL30150752 0.77 LMNA (0.59) CCR1CCR8SMN1; SMN2ADRA1AL3MBTL1
Ammonia Solution, Strong SCHEMBL28014320 0.77 LMNA (0.59) CCR1CCR8SMN1; SMN2ADRA1AL3MBTL1
SCHEMBL14224304 0.76 CCR1 (0.66) CCR1CCR8SMN1; SMN2ADRA1AL3MBTL1
SCHEMBL19007837 0.76 CCR1 (0.51) CCR1CCR8MEN1KMT2ASMN1; SMN2
SCHEMBL4164142 0.76 LMNA (0.66) CCR1CCR8SMN1; SMN2L3MBTL1NPC1
SCHEMBL22356952 0.75 ALDH1A1 (0.42) CCR1CCR8MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11696499-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-04 US disclosed
US-11678498-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-13 US disclosed
US-20180097186-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-04-05 US disclosed
US-9887244-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-06 US disclosed
US-20170373267-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-12-28 US disclosed
US-20170331048-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170294489-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-10-12 US disclosed
US-20170294613-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-10-12 US disclosed
US-20170294587-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-10-12 US disclosed
US-20170244043-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-24 US disclosed
US-20170179204-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180097186-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME C1S, C1R, C9 CCR1 57/4885CCR8 525/4885MEN1 595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.